This empirical study examines the manner in which artificial intelligence (AI) is transforming several sectors and the way it might help realize the full potential of people. The study employs an ...

More advanced AI chatbots are more likely to oversimplify complex scientific findings based on the way they interpret the data they are trained on, a new study suggests.

Generative AI chatbot for doctors called 'Prof. Valmed' earns E.U. approval. In the U.S., FDA is yet to issue guidelines on ...

Science is moving fast, but STEM hasn’t kept pace. At a time when we need more scientists, engineers, and healthcare professionals than ever, too many students are still being left behind. For ...

Single-cell RNA sequencing (scRNA-seq) provides a high throughput, quantitative and unbiased framework for scientists in many research fields to identify and characterize cell types within ...

In 82% of sepsis cases, the AI was accurate nearly 40% of the time. Previous attempts to use electronic tools to detect sepsis caught less than half that many cases and were accurate 2% to 5% of the ...

A deep-learning model trained on human data reveals that promoter mutations may explain a significant portion of unsolved ...

The benefit of Zemcelpro is its ability to induce neutrophil and platelet engraftment, as observed in two single-arm, open-label, phase 2 clinical studies. The decision by the CHMP was largely ...

Agenus, a clinical-stage immunotherapy company, and Noetik, an AI-focused multimodal biology start-up, have announced a research collaboration to develop predictive biomarkers for Agenus’s lead ...

The FDA has approved the first artificial intelligence tool to predict breast cancer risk. ‘Arrest Me. Let’s Go’: Newsom Responds to Trump’s Threat Elon Musk reveals drug test results ...

The Food and Drug Administration has approved the first artificial intelligence tool to predict breast cancer risk. It's designed to predict five-year breast cancer risk from a routine screening ...